Genmab — Maj 2021
-
J&J's new cancer drug leads a growing pipeline of dual-targeting antibodies https://www.biopharmadive.com/news/johnson-johnson-rybrevant-bispecific-antibody-pipeline/600696/
-
Pyt, hvis man den bedste...
-
from March, PRV-015 in the EMA paper mill - Human anti-interleukin-15 (IL-15) monoclonal antibody, EMEA-002775-PIP01-20, from Provention
Bio, Inc., for the treatment of coeliac disease; The PDCO adopted positive opinions for product-specific waivers, recommending that the obligation to
submit data obtained through clinical studies with children be waived in all subsets of the paediatric
population -
Servicemeddelese: Jeg har i dag overtaget 21 aktionær-aktiegrupper på Facebook. Forude forestår et større arbejde med implementeringen i Proinvestors univers . Det glæder jeg mig til at starte på sammen med et team af unge studerende på CBS og Syddansk Universitet.
-
Godmorgen og tillykke Helge. Du kan helt sikkert drive det vidt med de andre unge mennesker. De studerende får brug for dit energiske drive
-
God morgen.
-
Onsdagens aviser med Danske Bank, Novo Nordisk og Nordea
-
Tak Stroka og LLi.
-
The Lancet- Camidanlumab tesirine in patients with relapsed or refractory lymphoma: a phase 1, open-label, multicentre, dose-escalation, dose-expansion study https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(21)00103-4/fulltext https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(21)00139-3/fulltext
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind